Starting semaglutide six months after sleeve gastrectomy and its effects on long-term weight loss and metabolism

Adjunctive semaglutide therapy initiated six months after laparoscopic sleeve gastrectomy may influence long-term weight loss.

• Laparoscopic sleeve gastrectomy is an effective treatment for severe obesity, but some patients do not achieve optimal weight loss.
• Patients may experience weight-loss plateaus during postoperative follow-up.
• Semaglutide has shown effectiveness in obesity management, but its effects post-bariatric surgery are not well understood.
• The study evaluates the potential impact of adding semaglutide therapy on weight loss and metabolic outcomes after LSG.

Simplified